ANI Pharmaceuticals (NASDAQ:ANIP – Get Rating) updated its FY 2022 earnings guidance on Tuesday. The company provided earnings per share guidance of $1.34-$1.62 for the period, compared to the consensus earnings per share estimate of $1.15. The company issued revenue guidance of $295.00 million-$315.00 million, compared to the consensus revenue estimate of $292.77 million. Several […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Wall Street brokerages forecast that ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Rating) will report earnings per share of $0.08 for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for ANI Pharmaceuticals’ earnings. ANI Pharmaceuticals reported earnings of $1.04 per share in the same quarter last year, which suggests a negative year-over-year […]
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Rating) has earned an average recommendation of “Hold” from the six analysts that are currently covering the company, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month price objective among […]